SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 100 filers reported holding SCICLONE PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $142,000 | -87.3% | 12,901 | -87.5% | 0.00% | – |
| Q4 2016 | $1,114,000 | +536.6% | 103,066 | +669.1% | 0.00% | – |
| Q2 2016 | $175,000 | -67.2% | 13,400 | -72.3% | 0.00% | – |
| Q1 2016 | $533,000 | +85.1% | 48,433 | +54.6% | 0.00% | – |
| Q4 2015 | $288,000 | -56.9% | 31,328 | -67.4% | 0.00% | – |
| Q3 2015 | $668,000 | -65.2% | 96,183 | -50.7% | 0.00% | -100.0% |
| Q2 2015 | $1,917,000 | +80.7% | 195,210 | +63.0% | 0.00% | – |
| Q1 2015 | $1,061,000 | -55.9% | 119,739 | -56.4% | 0.00% | -100.0% |
| Q4 2014 | $2,406,000 | +95.0% | 274,571 | +53.2% | 0.00% | – |
| Q3 2014 | $1,234,000 | +232.6% | 179,200 | +154.0% | 0.00% | – |
| Q2 2014 | $371,000 | +46.1% | 70,544 | +26.6% | 0.00% | – |
| Q1 2014 | $254,000 | -41.2% | 55,731 | -35.0% | 0.00% | – |
| Q4 2013 | $432,000 | +14.0% | 85,741 | +14.7% | 0.00% | – |
| Q3 2013 | $379,000 | -66.0% | 74,772 | -66.8% | 0.00% | – |
| Q2 2013 | $1,116,000 | – | 225,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|